Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Nikos Iatropoulos
AddedMar 31, 2024
UpdatedMay 31, 2026
Nikos Iatropoulos

Nikos Iatropoulos

Board Member, AetherTouch

CrunchbaseLinkedIn

Nikos Iatropoulos's Career

AetherTouch
AetherTouch

Austin, TX, US

Board Member· Board
Tanvas
Tanvas

Chicago, IL, US

Board Member· Board
Behavioral Signals
Behavioral Signals

Los Angeles, CA, US

Board Member· Board
Linnaeus Therapeutics
Linnaeus Therapeutics

Haddonfield, NJ, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Nikos Iatropoulos's Career

AetherTouch
AetherTouch
Seed$1.1M22016Austin, TX, US
Board Member· Board

Leadership at AetherTouch

Travis BlakeTravis BlakeBoard Member

Similar to AetherTouch

Sense AISense AISaint Paul, MN, USProgramming Services, SDKest. 2014Sense AISaint Paul, MN, US · est. 2014

Founded in 2014, Ai Sense Inc provides SDKs and computer programming services for developers.

Seed · $1.5M1
CollabKitCollabKitLondon, Greater London, GBSDK, Softwareest. 2021CollabKitLondon, Greater London, GB · est. 2021

CollabKit: React SDK for collaborative SaaS features

Angel2
LibLabLibLabAustin, TX, USAPI, SDK Managementest. 2022LibLabAustin, TX, US · est. 2022

LibLab offers SDK management tools and API integration for enhanced security, error handling, and synced documentation.

Series A · $50M39
MidtypeMidtypePleasanton, CA, USDevelopment Toolsest. 2018MidtypePleasanton, CA, US · est. 2018

Midtype's SaaS Development Kit: Streamlining SaaS product development with user management, payment integration, and more.

Seed · $150k5
Tanvas
Tanvas
Series A$7.5M302011Chicago, IL, US
Board Member· Board

Leadership at Tanvas

Ben BuettellBen BuettellBoard Member
Behavioral Signals
Behavioral Signals
Series A$7M222016Los Angeles, CA, US
Board Member· Board

Leadership at Behavioral Signals

Shrikanth NarayananShrikanth NarayananCo-Founder
Alexandros PotamianosAlexandros PotamianosCo-Founder
Prem NatarajanPrem NatarajanCo-Founder
Rana GujralRana GujralCEO
Linnaeus Therapeutics
Linnaeus Therapeutics
Seed$23.8M82016Haddonfield, NJ, US
Board Member· Board

Leadership at Linnaeus Therapeutics

Patrick MooneyPatrick MooneyCEO
Christopher NataleChristopher NataleFounder

Similar to Linnaeus Therapeutics

Lassen TherapeuticsLassen TherapeuticsSan Diego, CA, USBiotherapeuticsest. 2019Lassen TherapeuticsSan Diego, CA, US · est. 2019

Lassen Therapeutics: Innovating best-in-class biotherapeutics for serious diseases.

Series B · $116M23
Grannus TherapeuticsGrannus TherapeuticsIndianapolis, IN, USCancer Treatmentest. 2020Grannus TherapeuticsIndianapolis, IN, US · est. 2020

Grannus Therapeutics: An Indianapolis-based biotech firm specializing in cancer treatment since 2020.

Pre-Seed · $1.8M2
Seneca TherapeuticsSeneca TherapeuticsBlue Bell, PA, USCancer Therapiesest. 2018Seneca TherapeuticsBlue Bell, PA, US · est. 2018

Seneca, a biotech company, innovates oncolytic immunotherapies for cancer treatment.

Series A · $7.7M7
Cullinan OncologyCullinan OncologyCambridge, MA, USOncology Therapeuticsest. 2016Cullinan OncologyCambridge, MA, US · est. 2016

Cullinan Oncology LLC: A US-based biopharmaceutical firm specializing in diversified oncology therapeutics.

Public · $389.7M93

Nikos Iatropoulos's Similar Executives & Operators

Jay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoYun SeokYun SeokBoard Member · Kakao

People Similar to Nikos Iatropoulos

Nick AscoliNick AscoliFounder · ForetracePuneeth PrasadPuneeth PrasadCo-Founder · WhatElseRob FriedmanRob FriedmanBoard Member · Digital EnvoyNick SuchNick SuchCo-Founder · BuildingLayerDaniel PetrozzoDaniel PetrozzoBoard Member · ExopriseAbinav SankarAbinav SankarBoard Member · Bekhealth